K2 Principal Fund, L.P. Ars Pharmaceuticals, Inc. Comm Transaction History
K2 Principal Fund, L.P.
- $384 Million
- Q3 2025
A detailed history of K2 Principal Fund, L.P. transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 63,200 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,200
Previous 317,126
80.07%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions